Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Oct 29, 2026
TickeronGET DAILY SIGNALS
Arthur J. Gallagher & Co. (AJG) Reports Q3 2026 Results with +18% Revenue Growth

Arthur J. Gallagher & Co. (AJG) Reports Q3 2026 Results with +18% Revenue Growth

Key Takeaways

  • Arthur J. Gallagher & Co. reported third quarter 2026 revenue of roughly $3.98 billion, up about 18% year over year but modestly below the roughly $4.00 billion consensus estimate.
  • Adjusted earnings per share (EPS) came in at $3.00, slightly above the consensus estimate of $2.99 and up from $2.31 a year earlier.
  • GAAP net earnings reached $406 million, or $1.55 per share, versus $273 million, or $1.04 per share, in the prior-year quarter.
  • Adjusted EBITDAC grew 25% to about $1.25 billion, marking a 26th consecutive quarter of double-digit growth.
  • Organic revenue growth was 5%, while the company completed five acquisitions during the quarter, adding roughly $102 million in estimated annualized revenue.

Why These Results Matter in Context

Arthur J. Gallagher & Co. ranks among the largest insurance brokerage and risk management firms globally, drawing revenue from commissions, fees, and claims-administration services. Its quarterly updates often reflect broader trends in commercial insurance pricing, client retention, and demand for risk services. The Q3 2026 report carried extra significance after the major AssuredPartners acquisition, which altered the revenue base and cost structure. I also checked this using Tickeron’s AI Screener to compare the stock against industry peers. Investors focused on whether AJG could extend its streak of double-digit adjusted EBITDAC growth despite softer pricing in some property and casualty lines and ongoing cost pressures from inflation.

Breaking Down the Q3 Numbers

For the third quarter of 2026, AJG reported total revenue of approximately $3.98 billion, an increase of roughly 18% from $3.365 billion in the same period last year. The figure landed slightly below the consensus estimate of about $4.00 billion, a top-line miss of roughly 0.6%. Combined Brokerage and Risk Management segment revenue grew 18%, including 5% organic growth, supported by strong client retention and new business.

On the bottom line, adjusted EPS of $3.00 edged past the consensus estimate of $2.99 and rose from $2.31 a year earlier. GAAP net earnings climbed to $406 million, or $1.55 per share, compared with $273 million, or $1.04 per share, in the prior-year period. Adjusted EBITDAC grew 25% to approximately $1.25 billion, extending the company’s streak of double-digit growth to 26 consecutive quarters, though it was marginally below the roughly $1.26 billion analysts had modeled. Management pointed to margin expansion and acquisition contributions as key drivers, while noting that lower interest-income revenue from prior-year AssuredPartners financing proceeds partially offset underlying performance. I also checked this using Tickeron’s AI Daily Buy/Sell Signals to review recent trading patterns around the release.

How the Market Responded

The market’s initial response to the report was measured. Shares traded near $268 and were little changed to slightly lower in after-hours action, as the modest revenue shortfall and a slightly light adjusted EBITDAC print were balanced against an in-line-to-better adjusted EPS and continued margin expansion. The subdued reaction reflected a quarter with few dramatic surprises: solid organic growth and acquisition contributions were already well anticipated, and the small top-line miss did not alter the broader narrative of resilient demand. Sentiment heading into the print had leaned cautious, with more downward than upward EPS revisions over the prior 90 days, so the steady results provided reassurance without triggering a sharp repricing.

What to Watch Going Forward

Looking ahead, investors will be watching whether organic growth can remain in the mid-single digits as insurance pricing conditions evolve across property and casualty lines. Renewal-rate trends, client retention, and new business generation will be key signals of the underlying demand environment.

The integration of AssuredPartners and the contribution from newly completed acquisitions remain central to the outlook. Management’s two-pronged strategy pairs organic expansion with deal activity, so the pace of future tuck-in acquisitions and the realization of cost synergies will influence both revenue growth and margin trajectory.

Cost trends also warrant attention. Compensation expense ratios, integration-related charges, and the lower interest-income contribution from prior financing proceeds could continue to shape profitability. A continued run of margin expansion alongside disciplined expense management would support the company’s long streak of adjusted EBITDAC growth, while any softening in organic growth or client activity could prompt investors to reassess valuation. From what I see, these factors will determine how sustainable the current momentum remains.

Exploring AI Tools in My Research

I often rely on Tickeron’s AI Screener to filter stocks by fundamentals, technical patterns, and industry trends. It provides a structured way to compare names like AJG against peers and surface relevant signals without manual effort. This approach has become a regular part of how I review quarterly results and sector positioning.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: AJG

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


AJG's RSI Oscillator recovers from overbought zone

The 10-day RSI Oscillator for AJG moved out of overbought territory on November 06, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 39 instances where the indicator moved out of the overbought zone. In 25 of the 39 cases the stock moved lower in the days that followed. This puts the odds of a move down at 64%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AJG as a result. In 36 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 43%.

The Moving Average Convergence Divergence Histogram (MACD) for AJG turned negative on November 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 20 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 45%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AJG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 51%.

AJG broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

AJG moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for AJG crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 61%.

Following a +3.50% 3-day Advance, the price is estimated to grow further. Considering data from situations where AJG advanced for three days, in 210 of 366 cases, the price rose further within the following month. The odds of a continued upward trend are 57%.

The Aroon Indicator entered an Uptrend today. In 165 of 347 cases where AJG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 48%.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 17 (best 1 - 100 worst), indicating outstanding price growth. AJG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 27 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 48 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock slightly better than average.

The Tickeron SMR rating for this company is 80 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 97 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.044) is normal, around the industry mean (2.794). P/E Ratio (46.166) is within average values for comparable stocks, (19.877). Projected Growth (PEG Ratio) (0.679) is also within normal values, averaging (8.322). Dividend Yield (0.010) settles around the average of (0.042) among similar stocks. P/S Ratio (4.021) is also within normal values, averaging (3.106).

Notable companies

The most notable companies in this group are eHealth (NASDAQ:EHTH).

Industry description

Insurance brokers sell, solicit, or negotiate insurance for compensation. General insurance brokers mostly cater to insurances on car, house etc. (versus life). Brokers are also often instrumental in helping small employers find health insurance, particularly in more competitive markets. Additionally, brokers may also provide risk assessments, insurance consulting services, insurance-related regulatory and legislative update services. Some of the major names in this industry include Marsh & McLennan Companies, Inc., Aon plc and Verisk Analytics Inc.

Market Cap

The average market capitalization across the Insurance Brokers/Services Industry is 16B. The market cap for tickers in the group ranges from 3.03K to 97.74B. MRSH holds the highest valuation in this group at 97.74B. The lowest valued company is CUII at 3.03K.

High and low price notable news

The average weekly price growth across all stocks in the Insurance Brokers/Services Industry was -9%. For the same Industry, the average monthly price growth was -6%, and the average quarterly price growth was 17%. CRVL experienced the highest price growth at 3%, while ZBAO experienced the biggest fall at -66%.

Volume

The average weekly volume growth across all stocks in the Insurance Brokers/Services Industry was -73%. For the same stocks of the Industry, the average monthly volume growth was 7% and the average quarterly volume growth was -5%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 59
P/E Growth Rating: 74
Price Growth Rating: 51
SMR Rating: 70
Profit Risk Rating: 84
Seasonality Score: 8 (-100 ... +100)
AI Screener 4
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of insurance brokerage and third-party claims settlement and administration services.

Industry InsuranceBrokersServices

Industry
Insurance Brokers Or Services
Address
2850 Golf Road
Phone
+1 630 773-3800
Employees
72000
Web
https://www.ajg.com
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.